Results 151 to 159 of about 26,382 (159)

RAS blocker effects on first HF hospitalization or CV death does not differ in Black and non-Black patients with HFrEF

Annals of Internal Medicine
SOURCE CITATION Shen L, Lee MMY, Jhund PS, et al. Revisiting race and the benefit of RAS blockade in heart failure: a meta-analysis of randomized clinical trials. JAMA. 2024;331:2094-2104. 38809561.
Paula Rambarat, L. K. Newby
semanticscholar   +1 more source

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.

The Lancet Haematology, 2020
P. Tacchetti, L. Pantani, F. Patriarca, M. Petrucci, E. Zamagni, L. Dozza, M. Galli, F. Di Raimondo, C. Crippa, M. Boccadoro, S. Barbato, P. Tosi, F. Narni, V. Montefusco, N. Testoni, A. Spadano, C. Terragna, N. Pescosta, G. Marzocchi, C. Cellini, P. Galieni, S. Ronconi, M. Gobbi, L. Catalano, A. Lazzaro, G. De Sabbata, C. Cangialosi, F. Ciambelli, P. Musto, F. Elice, M. Cavo   +30 more
semanticscholar   +1 more source

MMY (Mental Measurements Yearbooks)

Encyclopedia of Personality and Individual Differences, 2020

semanticscholar   +1 more source

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

, 2014
P. Tacchetti, L. Pantani, V. Stefano, E. Zamagni, J. Peccatori, A. Pezzi, C. Califano, A. Nozza, P. Tosi, C. Terragna, F. Ciambelli, D. Cangini, P. Galieni, C. Cangialosi, G. D. Sabbata, F. Elice, A. Palumbo, M. Cavo   +17 more
semanticscholar   +1 more source

Persistent Improvement In Clinical Outcomes With Bortezomib-Thalidomide-Dexamethasone Vs Thalidomide-Dexamethasone Incorporated Into Double Autologous Transplantation For Multiple Myeloma: An Updated Analysis Of Phase 3 Gimema-MMY-3006 Study

, 2013
M. Cavo, M. Galli, A. Pezzi, F. Raimondo, C. Crippa, M. Offidani, P. Tacchetti, V. Montefusco, F. Narni, A. Spadano, N. Pescosta, E. Zamagni, B. Gamberi, T. Caravita, A. Falcone, C. Nozzoli, R. Zambello, A. Furlan, A. Brioli, M. Boccadoro   +19 more
semanticscholar   +1 more source

Mmy-net: a multimodal network exploiting image and patient metadata for simultaneous segmentation and diagnosis

Multimedia Systems
Renshu Gu, Yueyu Zhang, Lisha Wang, Dechao Chen, Yaqi Wang, Ruiquan Ge, Zicheng Jiao, Juan Ye, Gangyong Jia, Linyan Wang   +9 more
semanticscholar   +1 more source

MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma.

, 2007
J. S. Miguel, R. Schlag, Nuriet K. Khuageva, O. Shpilberg, M. Dimopoulos, M. Kropff, I. Špička, M. Petrucci, O. Samoilova, A. Dmoszyńska, K. Abdulkadyrov, R. Schots, B. Jiang, A. Palumbo, M. Mateos, Kevin X. Liu, A. Cakana, H. Velde, P. Richardson   +18 more
semanticscholar   +1 more source

A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma

, 2010
P. Moreau, H. Pylypenko, S. Grosicki, E. Karamanesht, X. Leleu, M. Grishunina, G. Rekhtman, Z. Masliak, T. Robak, Anna V Shubina, J. Fermand, M. Kropff, J. Cavet, S. Parasuraman, Huaibao Feng, D. Skee, H. Velde, W. Deraedt, J. Harousseau   +18 more
semanticscholar   +1 more source

What stock-per recruit target can be applied to Japanese fisheries resources under large uncertainties in the stock-recruitment relationship?

Fisheries Science
M. Miyagawa, Momoko Ichinokawa
semanticscholar   +1 more source